Announced Mon, 13 Apr · 17:57 IST

Non-Applicability of Reg -57 (5) of SEBI LODR Regulations, 2015.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+8.4%1-day move

₹2.63

prior close

₹2.54

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0+3.9+8.4+18.6+17.5+11.8+11.8+8.4+14.8+21.7+10.3+32.7

Up moveDown movePending

AI summary

Transgene Biotek Ltd has informed BSE that Regulation 57(5) of SEBI (LODR) Regulations, 2015 does not apply to the company for the quarter ending March 31, 2026. The company stated it has not issued any non-convertible securities during this period. As a result, requirements to submit certificates about interest, dividend, or principal obligations on non-convertible securities are not applicable. This is a routine compliance filing confirming the company's debt securities status.

Likely market impact

This filing has no direct impact on shareholders or stock price. It simply confirms that the company has no non-convertible debt outstanding and is meeting its regulatory disclosure obligations under SEBI LODR.